Salina Scheiner
Adult Health · Rosedale, NYNPI 1932777885
Payments from drug & device makers
Across 187 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$700
- Lilly USA, LLC$330
- Novo Nordisk$271
- Bayer$236
- Antares Pharma, Inc.$190
- Merck$179
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $700 |
| Lilly USA, LLC | 16 | $330 |
| Novo Nordisk | 13 | $271 |
| Bayer | 11 | $236 |
| Antares Pharma, Inc. | 9 | $190 |
| Merck | 9 | $179 |
| Johnson & Johnson | 4 | $176 |
| GSK | 9 | $148 |
| Ardelyx, Inc. | 6 | $147 |
| Exact Sciences | 6 | $110 |
| Axsome Therapeutics, Inc. | 4 | $100 |
| Indivior Inc. | 5 | $96 |
| Intra-sana Laboratories | 5 | $94 |
| Hologic Sales And Service, LLC | 3 | $79 |
| Corcept Therapeutics | 4 | $79 |
| Renalytix AI, Inc. | 4 | $78 |
| Pfizer | 3 | $74 |
| AstraZeneca | 4 | $69 |
| Halozyme Inc | 3 | $67 |
| Alkermes, Inc. | 3 | $62 |
| Amgen | 3 | $59 |
| Medtronic | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Tolmar, Inc. | 2 | $31 |
| Gilead | 1 | $28 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Eisai Inc. | 1 | $23 |
| Clarus Therapeutics Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Resmed Corp | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Corium, LLC | 2 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Medicomp Inc | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$126
How this compares
$3,759 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $30,084 |
| EliquisApixaban | 27 | $28,511 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $1,976 |
| Rosuvastatin Calcium | 91 | $1,093 |
| Buprenorphine Hcl | 18 | $969 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $863 |
| Atorvastatin Calcium | 98 | $734 |
| Losartan Potassium | 94 | $640 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 33 | $496 |
| Metoprolol Succinate | 46 | $458 |
| Levothyroxine Sodium | 40 | $453 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $399 |
| Amlodipine Besylate | 70 | $349 |
| Omeprazole | 30 | $290 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $271 | $30,08432 claims |
| PfizerEliquis | $74 | $28,51127 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $20 | $45340 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.
Other adult health in Rosedale
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.